Transwell assays further bolstered our observations, showing that PRMT6 enhancement distinctly amplified the migration and invasion capabilities of cancer cells with STAT3 WT, yet failed to manifest this effect in cells with STAT3 R729K mutant (Fig. 7D and Supplementary Fig. 6A). The gene discussed is STAT3; the disease is cancer.